182 related articles for article (PubMed ID: 10360756)
1. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
Sum PE; Petersen P
Bioorg Med Chem Lett; 1999 May; 9(10):1459-62. PubMed ID: 10360756
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in tetracycline antibiotics.
Sum PE; Sum FW; Projan SJ
Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
[TBL] [Abstract][Full Text] [Related]
4. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
[TBL] [Abstract][Full Text] [Related]
6. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
Goldstein FW; Kitzis MD; Acar JF
Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.
Projan SJ
Pharmacotherapy; 2000 Sep; 20(9 Pt 2):219S-223S; discussion 224S-228S. PubMed ID: 11001329
[TBL] [Abstract][Full Text] [Related]
8. Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.
Nannini EC; Pai SR; Singh KV; Murray BE
Antimicrob Agents Chemother; 2003 Feb; 47(2):529-32. PubMed ID: 12543654
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines.
Whittington WL; Roberts MC; Hale J; Holmes KK
Antimicrob Agents Chemother; 1995 Aug; 39(8):1864-5. PubMed ID: 7486935
[TBL] [Abstract][Full Text] [Related]
10. The glycylcyclines: a comparative review with the tetracyclines.
Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ
Drugs; 2004; 64(1):63-88. PubMed ID: 14723559
[TBL] [Abstract][Full Text] [Related]
11. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria.
Wexler HM; Molitoris E; Finegold SM
Antimicrob Agents Chemother; 1994 Oct; 38(10):2513-5. PubMed ID: 7840601
[TBL] [Abstract][Full Text] [Related]
13. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP
J Med Chem; 1994 Jan; 37(1):184-8. PubMed ID: 8289194
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
Tuckman M; Petersen PJ; Projan SJ
Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.
Kitzis MD; Ly A; Goldstein FW
Antimicrob Agents Chemother; 2004 Jan; 48(1):366-7. PubMed ID: 14693571
[No Abstract] [Full Text] [Related]
16. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
Koza DJ; Nsiah YA
Bioorg Med Chem Lett; 2002 Aug; 12(16):2163-5. PubMed ID: 12127528
[TBL] [Abstract][Full Text] [Related]
17. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
Brown BA; Wallace RJ; Onyi G
Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
[TBL] [Abstract][Full Text] [Related]
19. Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.
Felmingham D
J Chemother; 2005 Aug; 17 Suppl 1():5-11. PubMed ID: 16285353
[TBL] [Abstract][Full Text] [Related]
20. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
Someya Y; Yamaguchi A; Sawai T
Antimicrob Agents Chemother; 1995 Jan; 39(1):247-9. PubMed ID: 7695316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]